Endocrinology Advisor23h
Polypharmacy Linked to Poor Outcomes After COVID-19 in Patients With Diabetes
Polypharmacy is associated with poor clinical outcomes following COVID-19 infection among patients with type 2 diabetes.
Scientific American1d
On COVID’s Fifth Anniversary, Scientists Reflect on Mistakes and Successes
Public health experts discuss lessons learned from the U.S. response to the COVID pandemic, on topics ranging from school ...
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™(pemivibart) against LP.8.1 Centers for Disease ...
Invivyd announces in vitro neutralization data for PEMGARDA
Invivyd (IVVD) announced positive, continued, clinically meaningful in vitro neutralization data for PEMGARDA against the currently dominant ...